Clinical Trials Directory

Trials / Completed

CompletedNCT06290076

A Predictive Model and Scoring System for Severe Complications After Endovascular Thrombectomy

A Predictive Model and Scoring System for Severe Complications After Endovascular Thrombectomy: a Retrospective, Multicenter, Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,500 (actual)
Sponsor
Xuanwu Hospital, Beijing · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

To establish a predictive model and scoring system for predicting severe complications after thrombectomy. This scoring system can be used to identify high-risk patients after endovascular thrombectomy, guide the early use of adjunctive interventions, and provide reference for future clinical trials.

Detailed description

Acute ischemic stroke (AIS) accounts for about 80% of all strokes. The focus of AIS treatment is to restore reperfusion of ischemic territory as soon as possible, promote neurological recovery, reduce disability rate and improve long-term survival rate. In recent years, a series of randomized clinical trials have proved that endovascular thrombectomy (EVT) is safe and effective in the treatment of anterior circulation AIS. EVT has been recommend as the first-line treatment for anterior circulation large vessel occlusion (LVO) stroke by guidelines. Symptomatic intracranial hemorrhage (sICH) and malignant cerebral edema (MCE) are the two most common severe neurological complications, leading to brain tissue hypoxia and neurological dysfunction. Currently, there is a lack of prediction system to identify patients at high risk for severe complications, who can most likely benefit from adjuvant treatment after thrombectomy to improve patient functional independence and survival rate.

Conditions

Timeline

Start date
2020-01-01
Primary completion
2023-06-30
Completion
2023-09-30
First posted
2024-03-04
Last updated
2024-03-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06290076. Inclusion in this directory is not an endorsement.